INO — INOVIO PHARMACEUTICALS INC

Ownership history in XTX Topco Ltd · 5 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in INOVIO PHARMACEUTICALS INC (INO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

0.03% (2025 Q3)

Avg. % of fund

0.01%

First filed

2024 Q4

Last filed

2025 Q4

Quarters held

5

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q4	REDUCED	167,037	-43,530	-20.7%	0.01%	$291K	$1.74
2025 Q3	ADDED	210,567	+188,529	+855.5%	0.03%	$493K	$2.34
2025 Q2	REDUCED	22,038	-44,131	-66.7%	0.00%	$45K	$2.04
2025 Q1	ADDED	66,169	+13,939	+26.7%	0.01%	$108K	$1.63

% of Fund (quarterly) INO price (monthly, adj. close)

Other funds also holding INO

As of 2025 Q4 — sorted by position size

ADAR1 Capital Management, LLC 0.19% Green Alpha Advisors, LLC 3Y 0.11% Persistent Asset Partners Ltd 0.11% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.07% 683 Capital Management, LLC 3Y 7Y 0.02% ADAR1 Capital Management, LLC 0.01% ADAGE CAPITAL PARTNERS GP, L.L.C. 3Y 7Y 0.01% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.01% Covestor Ltd 3Y 0.01% Virtu Financial LLC 3Y 7Y 0.0%

← Back to XTX Topco Ltd Holdings